Fundraising Fox
RxE2
Fargo, US · Founded 2021 · Delaware corporation
Find your way into RxE2
26 people in our graph share verified history with the RxE2 team — schools, employers, funds. One of them is your warm intro.
Susanne Seripierounlockedknows Gerald Finken · together at Kean University (overlapped)
×9knows the team · via Rutgers University
knows the team · via Veterans Administration Hospital
knows the team · via PRACS Institute
RxE2 runs community-based clinical trials by using community pharmacies as clinical sites, connecting trial sponsors with a network of pharmacies for patient recruitment, direct patient access, and decentralized trial visits. It operates in the clinical research and pharmaceutical trials sector.
Founders & leadership
RxE2 was founded in 2021 by Gerald Finken and Gerald E. Finken, R.Ph., M.S..
GF
Gerald FinkenCo-founder · Chief Executive OfficerGerald Finken founded CSM in 1997, a clinical supply organization, and later created the CTRP® (Clinical Trials Research Pharmacist) services division before launching Center Point Clinical Services in 2014; he holds a pharmacy degree and has over 40 years of experience in pharmacy practice and clinical research.
GE
Gerald E. Finken, R.Ph., M.S.Co-founder · Chief Executive OfficerA pharmacist by training, Finken founded Clinical Supplies Management (CSM) in 1997 and led it as CEO until 2016, later serving as its Chief Scientific Officer. He also founded Center Point Clinical Services, where he served as Chairman of the Board and then Chief Executive Officer before moving into his current role in 2020.
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 3 of 4 rounds · 2021
▶$1offeredApr 2021 · OtherRule 506(b)
▶$1offeredApr 2021 · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gerald E. FinkenExecutive Officer, Director
- Offering amount
- $1
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2MraisedApr 2021 · OtherRule 506(b)
▶$2MraisedApr 2021 · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gerald E. FinkenExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.5MraisedApr 2021 · 9 investors · OtherRule 506(b)
▶$3.5MraisedApr 2021 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gerald FinkenExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1raisedApr 2021 · 4 investors · OtherRule 506(b)
▶$1raisedApr 2021 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gerald FinkenExecutive Officer, Director
- Offering amount
- $1
- Amount sold
- $1
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapRedsail Technologies11 shared keywordsRedSail Technologies provides pharmacy management systems and integrated pharmacy solutions serving health systems and pharmacy operations across the United States. The company delivers software, automation, and clinical programs to optimize medication management and patient care outcomes in healthcare settings.
RxAnte9 shared keywordsRxAnte provides tech-enabled, value-based pharmacy care management, including analytics and quality-improvement tools plus high-touch pharmacy services, for health plans, providers, and pharmacies. Its programs aim to improve medication use and health outcomes for at-risk members while lowering healthcare costs.
RxVantage8 shared keywordsPlatform connecting healthcare providers with life science experts to access critical information and insights.
Companies competing with RxE2 for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does RxE2 do?
- RxE2 runs community-based clinical trials by using community pharmacies as clinical sites, connecting trial sponsors with a network of pharmacies for patient recruitment, direct patient access, and decentralized trial visits. It operates in the clinical research and pharmaceutical trials sector.
- Who founded RxE2?
- RxE2 was founded by Gerald Finken, Gerald E. Finken, R.Ph., M.S. in 2021.
- How much funding has RxE2 raised?
- RxE2 has disclosed $5.5M raised across 3 of its 4 known rounds.
- Where is RxE2 headquartered?
- RxE2 is headquartered in Fargo, US.